← Home
Mesa Laboratories
-14.47%
Testing / Quality control instruments and services
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-01-07 17:00:00 | Mesa Labs Declares Quarterly Dividend Lakewood, colo., jan. 07, 2026 (globe newswire) -- mesa laboratories, inc. (nasdaq:mlab) (we, us, our, “mesa” or the “company”) today announced that its board of directors has declared a regular quarterly dividend of $0.16 per share of common stock. the dividend will be payable on march 16, 2026, to shareholders of record at the close of business on february 28, 2026. |
| 2025-12-18 19:00:00 | Mesa Labs To Present At The 44th Annual J.p. Morgan Healthcare Conference On January 14, 2026 Lakewood, colo., dec. 18, 2025 (globe newswire) -- mesa laboratories, inc. (nasdaq:mlab), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that gary owens, president and ceo, and john sakys, cfo will present at the 44th annual j.p. morgan healthcare conference on wednesday, january 14th, 2026. management will participate in a formal presentation at 4:30 p.m. pacific time. |
| 2025-11-12 15:14:00 | Mesa Laboratories, Inc. To Participate In Upcoming Investor Conferences Lakewood, colo., nov. 12, 2025 (globe newswire) -- mesa laboratories, inc. (nasdaq:mlab) today announced that gary owens, president and ceo, and john sakys, cfo will be attending the following upcoming conferences: |
| 2025-10-03 11:46:00 | Mesa Laboratories, Inc. To Announce Second Quarter Results On November 6, 2025 Lakewood, colo., oct. 03, 2025 (globe newswire) -- mesa laboratories, inc. (nasdaq:mlab) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on thursday, november 6, 2025. |
| 2025-08-18 14:01:00 | Mesa Laboratories Executes Previously-announced Strategic Financing Plan Lakewood, colo., aug. 18, 2025 (globe newswire) -- mesa laboratories, inc. (nasdaq: mlab) (we, us, our, “mesa” or the “company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the company’s 1.375% convertible senior notes due august 2025 (the “2025 notes”). on august 12, 2025, the company drew $97.0 million under its existing amended and restated credit agreement (the “credit agreement”), bringing the total outstanding balance to $108 million. the proceeds from the draw were used to settle the 2025 notes that matured on august 15, 2025. |
| 2025-07-03 12:00:00 |
|
| 2025-07-02 15:20:00 |
|
| 2025-05-28 08:00:00 |
|
| 2025-04-07 15:00:00 |
|
| 2025-02-04 08:00:00 |
|
| 2025-01-17 13:15:00 |
|
| 2025-01-06 15:00:00 |
|
| 2024-11-07 08:00:00 |
|
| 2024-10-02 14:00:00 |
|
| 2024-08-05 08:00:00 |
|
📰 Browse additional press releases for Mesa Laboratories!
Sign up for free or log in✍️ Sign up to get "The Checklist Value Investor — A Smarter Way to Pick Stocks" for free